Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:576584.
doi: 10.1155/2012/576584. Epub 2012 Jul 16.

HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients

Matheus Truccolo Michalczuk  1 , Camila Rippol Kappel, Oscar Birkhan, Ana Carolina Bragança, Mário Reis Alvares-da-Silva
Affiliations

HOMA-AD in Assessing Insulin Resistance in Lean Noncirrhotic HCV Outpatients

Matheus Truccolo Michalczuk et al. Int J Hepatol. 2012.

Abstract

Introduction. There is an association between HCV and insulin resistance (IR), which is currently assessed by HOMA-IR. There is evidence that HOMA-adiponectin (HOMA-AD) is more accurate, but its role in HCV patients is unknown. The purpose of this study was to evaluate IR in an HCV sample and controls, in order to compare the accuracy of HOMA-IR and HOMA-AD. Methods. Ninety-four HCV outpatients aged <60 years who met the criteria of nondiabetic, nonobese, noncirrhotic, and nonalcohol abusers were included and compared to 29 controls. Fasting glucose, insulin, adiponectin, and lipid profiles were determined. IR was estimated by HOMA-IR and HOMA-AD. Results. The groups were similar regarding sex and BMI, but the HCV patients were older. The median insulin level was higher in the HCV group (8.6 mU/mL (6.5-13.7) versus 6.5 (4.3-10.7), P = 0.004), as was median HOMA-IR (1.94 (1.51 to 3.48) versus 1.40 (1.02 to 2.36), P = 0.002) and the prevalence of IR (38.3% versus 10.3% (P = 0.009)). No differences were found in adiponectin levels (P = 0.294) and HOMA-AD (P = 0.393). Conclusion. IR is highly prevalent even in low-risk HCV outpatients. Adiponectin is not influenced by the presence of HCV. HOMA-AD does not seem to be useful in assessing IR in HCV patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Spearman's correlation coefficient between HOMA-IR and HOMA-AD in the general sample, HCV, and control group.
See this image and copyright information in PMC

References

    1. Seeff LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. The New England Journal of Medicine. 1992;327:1906–1911. - PubMed
    1. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The Lancet. 1997;349(9055):825–832. - PubMed
    1. Narita R, Abe S, Kihara Y, Akiyama T, Tabaru A, Otsuki M. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. Journal of Hepatology. 2004;41(1):132–138. - PubMed
    1. Lonardo A, Adinolfi LE, Petta S, Craxi A, Loria P. Hepatitis C and diabetes: the inevitable coincidence? Expert Review of Anti-Infective Therapy. 2009;7(3):293–308. - PubMed
    1. Moriya K, Yotsuyanagi H, Shintani Y, et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. Journal of General Virology. 1997;78(7):1527–1531. - PubMed